Cfa Medical Winston Salem, NC - 27106

Cfa Medical is categorized under Drugs, Proprietaries, and Sundries in Winston Salem, NC and active since 1982.

Cfa Medical was established in 1982, and today employs 1 to 4, earning $1.000.000 to $2.499.999 per year. This is a Drugs, Proprietaries, and Sundries business, which does work in the B2C market, and is classified as a Drugs, Proprietaries, and Sundries, under code number 4461100 by the NAICS.

If you are seeking more information, feel free to contact Will Partin, Owner at the company’s single location by writing to 3911 Reynolda Road, Winston Salem, North Carolina NC 27106 or by phoning (336) 922-3916. You can also visit this business on Facebook by going to their profile page at Facebook or on find them on Twitter.

Business Name: Cfa Medical
Contact Person: Will Partin, Owner
Address: 3911 Reynolda Road, Winston Salem, North Carolina 27106
Phone Number: (336) 922-3916
Website Address: cfamedical.com
Annual Revenue (USD): $1.000.000 to $2.499.999
Founded: 1982
Location Type: Single Location
Employee Number: 1 to 4
Business Type: B2C (Business to Consumer)
Business Category: Drugs, Proprietaries, and Sundries
SIC Code: 5122
NAICS Code: 4461100
Share This Business:

Cfa Medical was started in 1982 to provide professional Drugs, Proprietaries, and Sundries under the SIC code 5122 and NAICS code 4461100. Since its inception, the company has gone on to take a total of 1 to 4 personnel under its employment and has achieved earnings of $1.000.000 to $2.499.999 per annum.

Feel free to contact Will Partin, Owner for inquiries that concern Cfa Medical by calling the company number (336) 922-3916, as your correspondence is most welcome. Additionally, the physical location of the single location of Cfa Medical can be found at the coordinates 36.1651,-80.33077 as well as the street address 3911 Reynolda Road in Winston Salem, North Carolina 27106.

For its online presence, you may visit Cfa Medical’s website at cfamedical.com and engage with its social media outlets through on Twitter and on Facebook.